Literature DB >> 17450007

Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation.

Bilal F Khan1, Mona Harissi-Dagher, Danish M Khan, Claes H Dohlman.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17450007     DOI： 10.1097/IIO.0b013e318036bd8b

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  29 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

2.  Glaucoma associated with Boston type I keratoprosthesis.

Authors:  Roheena Kamyar; Jennifer S Weizer; Fernando Heitor de Paula; Joshua D Stein; Sayoko E Moroi; Denise John; David C Musch; Shahzad I Mian
Journal:  Cornea       Date:  2012-02       Impact factor: 2.651

3.  Corneal regeneration following implantation of a biomimetic tissue-engineered substitute.

Authors:  Per Fagerholm; Neil S Lagali; David J Carlsson; Kimberley Merrett; May Griffith
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

4.  Boston type 1 keratoprosthesis for severe blinding vernal keratoconjunctivitis and Mooren's ulcer.

Authors:  Sayan Basu; Mukesh Taneja; Virender S Sangwan
Journal:  Int Ophthalmol       Date:  2011-03-22       Impact factor: 2.031

5.  Boston type 1 keratoprosthesis for failed keratoplasty.

Authors:  Jonathan L Hager; David L Phillips; Kenneth M Goins; Anna S Kitzmann; Mark A Greiner; Alex W Cohen; Jeffrey D Welder; Michael D Wagoner
Journal:  Int Ophthalmol       Date:  2015-05-16       Impact factor: 2.031

6.  Boston Keratoprosthesis: expanding the boundaries.

Authors:  Mona Harissi-Dagher
Journal:  Digit J Ophthalmol       Date:  2011-11-03

7.  Evaluation of immersion 20 MHz B-scan ultrasonography in observing lens in the alkali burn eyes.

Authors:  Qing-Hua Yang; Bing Chen; Li-Qiang Wang; Guang-Hua Peng; Zhao-Hui Li; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

8.  Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice.

Authors:  Hongshan Liu; Jianhua Zhang; Chia-Yang Liu; I-Jong Wang; Martin Sieber; John Chang; James V Jester; Winston W Y Kao
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA.

Authors:  Jared D Ament; Sandra J Spurr-Michaud; Claes H Dohlman; Ilene K Gipson
Journal:  Cornea       Date:  2009-08       Impact factor: 2.651

Review 10.  Current and Upcoming Therapies for Ocular Surface Chemical Injuries.

Authors:  Alireza Baradaran-Rafii; Medi Eslani; Zeeshan Haq; Ebrahim Shirzadeh; Michael J Huvard; Ali R Djalilian
Journal:  Ocul Surf       Date:  2016-09-17       Impact factor: 5.033
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.